Johnson & Johnson reminded everyone in medtech that it was a force to be reckoned with by presenting stellar 2Q23 earnings. And during an earnings call, the New Brunswick, NJ-based company’s executives noted that it was hungry for deals.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,